about
Development of a PCR-enzyme immunoassay oligoprobe detection method for Toxoplasma gondii oocysts, incorporating PCR controlsToxoplasmosis: A history of clinical observationsTgICMAP1 is a novel microtubule binding protein in Toxoplasma gondii.Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene.The role of serology in active ocular toxoplasmosis.Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokinesThe global burden of congenital toxoplasmosis: a systematic reviewGenotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis.CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.Molecular diagnosis of toxoplasmosis.Toxoplasmosis, an overview with emphasis on ocular involvement.Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomography.Management of toxoplasmic retinochoroiditis during pregnancy, postpartum period and lactation: clinical observations.Is ocular toxoplasmosis caused by prenatal or postnatal infection?Toxoplasma gondii effectors are master regulators of the inflammatory response.An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in IndiaRecently acquired Toxoplasma gondii infection, Brazil.A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis.Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil.Determinants of immunodiagnostic success in human ocular toxoplasmosis.Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondiiToxoplasmosis - An update.Toxoplasma serotype is associated with development of ocular toxoplasmosisContributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis.Ocular toxoplasmosis: the influence of patient age.Contributions to the history of ocular toxoplasmosis in Southern Brazil.A 26-year-old man with a blind spot in his left eye.Acquired ocular toxoplasmosis in pregnancy.Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate.The role of MHC haplotypes H2d/H2b in mouse resistance/susceptibility to cyst formation is influenced by the lineage of infective Toxoplasma gondii strain.Hypersensitivity reaction to intravitreal clindamycin therapy.
P2860
Q23916036-C095865B-BE56-48BC-BBA2-8DF02556159BQ24655325-1FE2A778-6A27-4D4D-BA63-3B88D2A4310BQ33510162-88761230-2D2E-44E1-AB90-762DC5CF43EAQ33971064-C683C96F-90AC-42B9-A321-0E90AAA4ACDDQ34246182-B55C28BC-0F64-4563-9378-1B413B68DA6EQ34315648-E606D8C4-3179-46CF-9C63-D0161881592FQ34355437-35049315-1345-4ED1-997B-10E1743F0ED6Q34569242-009D838D-7E6D-46D8-9EED-DC3819DB0C1EQ34646719-BE0412A7-32D3-422F-AF89-B903D679B411Q34677153-1FE34231-E450-45C7-B389-0DADDE8B6614Q35014158-5258BCCD-954C-43DD-B976-DBE6FBC21F7EQ35088071-CECCC524-523D-4A67-9ABE-436011312A2DQ35151320-8808305B-F5A4-4854-B0BA-2B2FFE329304Q35313234-2DF12DA7-5E19-4F72-B336-D6C234C351A8Q35434828-0ED30F0F-BC4A-4280-8BDC-77BC383B3DE6Q35606250-27126E9C-7378-4749-A022-D9E482E5E817Q35805596-659ED2FB-3387-418D-ADA5-FEFF4EB254C8Q35862823-6D24A992-0349-4686-9878-85529E82D364Q36026193-B65F3314-0545-46A9-9B66-893EE29EA699Q36120920-8D5E1AD5-E293-4A23-BF4D-17CC12979514Q36374668-BF6E7E89-4A46-4FA6-BE57-E21742962D11Q36671583-D4A72E7E-2345-4D33-A053-22831995E200Q37212995-850D7645-6042-46F2-87F9-CB1DB17ECC1CQ37256418-66A99975-6F8C-4E15-A283-238930FE2110Q37476779-E3435D69-A27A-4F71-A448-04D746F22E89Q39980892-BE7076B0-7C6B-41BB-88DE-C4CE7A1FE0BAQ41882344-C8A58AA6-7ED9-461D-85FF-2F3E9D91BA7FQ43009381-1EBF4E03-949F-414B-B9B5-D8F9F42D7FC5Q43175539-C00CF3D2-E45D-496C-9CE6-3EABE33F245CQ43698054-5D309192-4D1D-4EAC-BF6F-7A79E1A17FF2Q43910608-19CC1E9B-5758-46A0-871A-DA37D0481821
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Reconsidering the pathogenesis of ocular toxoplasmosis.
@ast
Reconsidering the pathogenesis of ocular toxoplasmosis.
@en
type
label
Reconsidering the pathogenesis of ocular toxoplasmosis.
@ast
Reconsidering the pathogenesis of ocular toxoplasmosis.
@en
prefLabel
Reconsidering the pathogenesis of ocular toxoplasmosis.
@ast
Reconsidering the pathogenesis of ocular toxoplasmosis.
@en
P1476
Reconsidering the pathogenesis of ocular toxoplasmosis.
@en
P2093
Holland GN
P304
P356
10.1016/S0002-9394(99)00263-9
P407
P577
1999-10-01T00:00:00Z